Abstract
Background
Health-related quality of life (HRQoL) is an essential outcome of health care, but there is no gold standard of HRQoL measurement. We investigated the impact of major chronic conditions on HRQoL using 15D and EQ-5D in a representative sample of Finns.
Methods
Information on chronic somatic conditions was obtained by interviews. Psychiatric disorders were diagnosed using a structured interview (M-CIDI). Tobit and CLAD regression analysis was used to estimate the impact of conditions on HRQoL at the individual and population level.
Main results
Adjusted for other conditions and sociodemographic variables, Parkinson’s disease had the largest negative impact on HRQoL at the individual level, followed by anxiety disorders, depressive disorders and arthrosis of the hip and knee. Based on prevalence, arthrosis of the hip or knee, depression, back problems and urinary incontinence caused the greatest loss of HRQoL at the population level. The results obtained with the two HRQoL measures differed markedly for some conditions and the EQ-5D results also varied with the regression method used.
Conclusions
Musculoskeletal disorders are associated with largest losses of HRQoL in the Finnish population, followed by psychiatric conditions. Different HRQoL measures may systematically emphasize different conditions.
Similar content being viewed by others
Abbreviations
- CLAD:
-
Censored least absolute deviations
- DSM-IV:
-
Diagnostic and Statistical Manual of Mental Disorders, 4th edition
- HRQoL:
-
Health-related quality of life
- HUI:
-
Health Utilities Index
- M-CIDI:
-
Munich-Composite International Diagnostic Interview
- QALY:
-
Quality-adjusted life year
- YLD:
-
Years lived with disability
References
Bowling A (1996) The effects of illness on quality of life: Findings from a survey of households in Great Britain. J Epidemiol Community Health 50: 149–155
Tengs TO, Wallace A. (2000) One thousand health-related quality-of-life estimates. Med Care 38: 583–637
Sullivan PW, Lawrence WF, Ghushchyan V (2005) A national catalog of preference-based scores for chronic conditions in the United States. Med Care 43: 736–749
Aromaa A, Koskinen S (eds). (2004) Health and Functional Capacity in Finland. Baseline Results of the Health 2000 Health Examination Survey, Helsinki
OECD (1982) The OECD List of Social Indicators. Organisation for Economic Co-operation and Development, Paris
Pirkola SP, Isometsa E, Suvisaari J, et al. (2005) DSM-IV mood-, anxiety- and alcohol use disorders and their comorbidity in the Finnish general population results from the Health 2000 Study. Soc Psychiatry Psychiatr Epidemiol 40: 1–10
Wittchen HU, Lachner G, Wunderlich U, et al. (1998) Test–retest reliability of the computerized DSM-IV version of the Munich-Composite International Diagnostic Interview (M-CIDI). Soc Psychiatry Psychiatr Epidemiol 33: 568–578
Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington: American Psychiatric Association, 1994
EuroQol – a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy 1990; 16: 199–208
Brooks R. (1996) EuroQol: The current state of play. Health Policy 37: 53–72
Rabin R, de Charro F. (2001) EQ-5D: A measure of health status from the EuroQol Group. Ann Med 33: 337–340
Kind P, Hardman G, Macran S. UK Population Norms for EQ-5D. In: Discussion Paper 172. University of York: The Centre for Health Economics, 1999
Dolan P, Gudex C, Kind P, et al. (1996) The time trade-off method: Results from a general population study. Health Econ 5: 141–154
Dolan P (1997) Modeling valuations for EuroQol health states. Med Care 35: 1095–1108
Garratt A, Schmidt L, Mackintosh A, et al. (2002) Quality of life measurement: Bibliographic study of patient assessed health outcome measures. Br Med J 324: 1417
Sintonen H (1994) The 15D Measure of Health Related Quality of Life: Reliability, Validity and Sensitivity of its Health State Descriptive System. Working Paper 41. Centre for Health Program Evaluation Monash University, Melbourne
Sintonen H. (1995) The 15D Measure of Health Related Quality of Life. II Feasibility, Reliability and Validity of its Valuation System. Working Paper 42. Centre for Health Program Evaluation, Monash University, Melbourne
Sintonen H (2001) The 15D instrument of health-related quality of life: Properties and applications. Ann Med 33: 328–336
Hawthorne G, Richardson J, Day NA. (2001) A comparison of the Assessment of Quality of Life (AQoL) with four other generic utility instruments. Ann Med 33: 358–370
Stavem K, Bjornaes H, Lossius MI. (2001) Properties of the 15D and EQ-5D utility measures in a community sample of people with epilepsy. Epilepsy Res 44: 179–189
Tobin J. (1958) Estimation of relationships for limited dependent variables. Econometrica 26: 24–36
Austin PC, Escobar M, Kopec JA (2000) The use of the Tobit model for analyzing measures of health status. Qual Life Res 9: 901–910
Cong R. Marginal effects for the tobit model. Stata Tech Bull 2000; 56: 27–34
Austin PC (2002) A comparison of methods for analyzing health-related quality-of-life measures. Value Health 5: 329–337
Clarke P, Gray A, Holman R. (2002) Estimating utility values for health states of type 2 diabetic patients using the EQ-5D (UKPDS 62). Med Decis Making 22: 340–349
Dolan P (2000) The measurement of health-related quality of life for use in resource allocation decisions in health care. In: Culyer AJ, Newhouse JP (eds), Handbook of Health Economics. Amsterdam: Elsevier, pp. 1723–1760
Austin PC (2002) Bayesian extensions of the Tobit model for analyzing measures of health status. Med Decis Making 22: 152–162
Wooldridge JM. Corner solution outcomes and censored regression models. In: Econometric Analysis of Cross Section and Panel Data. Cambridge, Massachusetts: The MIT Press, 2002: 517–549
Ruud PA (1984) Tests of Specification in Econometrics. Econ Rev 3: 211–242
Holden D (2004) Testing the normality assumption in the Tobit model. J Appl Stat 31: 521–532
Powell J (1984) Least absolute deviations estimation for the censored regression model. J Econ 25: 303–325
Ohinmaa A, Sintonen H. Inconsistencies and modelling of the Finnish EuroQol (EQ-5D) preference values. In: Greiner W, Graf V, Schulenburg J-M, et al. (eds), Plenary Meeting Hannover 1998, 1st-2nd October, Discussion Papers. Hannover: Uni-Verlag Witte; 1999: 57–74
STATA (2003) Users Guide Release 8. Stata Press, College Station, TX
Migon HS, Gamerman D. Statistical Inference: An Integrated Approach: Arnold, 1999
Schultz SE, Kopec JA (2003) Impact of chronic conditions. Health Rep 14: 41–53
Johnson JA, Ohinmaa A, Murti B, et al. (2000) Comparison of Finnish and U.S.-based visual analog scale valuations of the EQ-5D measure. Med Decis Making 20: 281–289
Sintonen H, Weijnen T, Nieuwenhuizen M, et al. (2003) Comparison of EQ-5D valuations: Analysis of background variables. In: Brooks R, Rabin R, de Charro F (eds), The Measurement and Valuation of Health Status using EQ-5D: A European Perspective. Evidence from the EuroQoL BIOMED Research Programme. Kluwer Academic Publishers, Dordrecht, pp. 81–101
Macran S, Weatherly H, Kind P (2003) Measuring population health: A comparison of three generic health status measures. Med Care 41: 218–231
Johnson JA, Coons SJ (1998) Comparison of the EQ-5D and SF-12 in an adult US sample. Qual Life Res 7: 155–166
Johnson JA, Pickard AS (2000) Comparison of the EQ-5D and SF-12 health surveys in a general population survey in Alberta, Canada. Med Care 38: 115–121
Burstrom K, Johannesson M, Diderichsen F (2001) Health-related quality of life by disease and socio-economic group in the general population in Sweden. Health Policy 55: 51–69
Burstrom K, Johannesson M, Diderichsen F (2001) Swedish population health-related quality of life results using the EQ-5D. Qual Life Res 10: 621–635
Mittmann N, Trakas K, Risebrough N, et al. (1999) Utility scores for chronic conditions in a community-dwelling population. Pharmacoeconomics 15: 369–376
Manuel DG, Schultz SE, Kopec JA. (2002) Measuring the health burden of chronic disease and injury using health adjusted life expectancy and the Health Utilities Index. J Epidemiol Community Health 56: 843–850
Fryback DG, Dasbach EJ, Klein R, et al. (1993) The Beaver Dam Health Outcomes Study: Initial catalog of health-state quality factors. Med Decis Making 13: 89–102
Lubetkin EI, Jia H, Franks P, et al. (2005) Relationship among sociodemographic factors, clinical conditions, and health-related quality of life: Examining the EQ-5D in the U.S. General Population. Qual Life Res 14: 2187–2196
Murray CJ, Lopez AD (eds) (1996) The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability From Diseases, Injuries and Risk Factors in 1990 and Projected to 2020. Harvard University Press, Boston, Mass
WHO. The World Health Report 2001: Mental Health: New Understanding. New Hope: World Health Organization, 2001
Melse JM, Essink-Bot ML, Kramers PG, et al. (2000) A national burden of disease calculation: Dutch disability-adjusted life-years. Dutch Burden of Disease Group. Am J Public Health 90: 1241–1247
Kohn R, Saxena S, Levav I, et al. (2004) The treatment gap in mental health care. Bull World Health Organ 82: 858–866
Colman SS, Brod M, Potter LP, et al. (2004) Cross-sectional 7-year follow-up of anxiety in primary care patients. Depress Anxiety 19: 105–111
Acknowledgements
SIS received grants from the Signe and Ane Gyllenberg Foundation, the Yrjö Jahnsson Foundation and the Finnish Medical Foundation.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Saarni, S.I., Härkänen, T., Sintonen, H. et al. The Impact of 29 Chronic Conditions on Health-related Quality of Life: A General Population Survey in Finland Using 15D and EQ-5D. Qual Life Res 15, 1403–1414 (2006). https://doi.org/10.1007/s11136-006-0020-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11136-006-0020-1